Drug Delivery Markets, 2nd Edition, Vol II: Implantable / Injectable Delivery Systems (Markets for Needle-Free, Targeted Injectable, Sustained-Release Implantable and Other Systems)

    Published: February 1, 2007 | Price: $2,995.00 – $4,990.00

    Fueled by the promise of needle-free mechanisms for vaccine distribution and other pharmaceutical uses, the implantable/injectable drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to continued growth. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products. The implantable/injectable delivery drug market is a expected to grow to over $12 billion by 2010. Kalorama’s Drug Delivery Markets. Edition...
    Cancer Therapeutics: The Worldwide Market , 2nd Edition

    Published: February 1, 2007 | Price: $2,500.00 – $7,990.00

    With over 6,160 individual data points reflecting useful market data, Kalorama's Cancer Therapeutics: The Worldwide Market, 2nd Edition is the most comprehensive and recent information available on the five key cancer therapy and treatment markets in a syndicated market research report, including the following areas: Chemotherapy, including -Subcategories Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives -Brands such as Elotaxin, Taxotere, Gemzar, Alimta and Temodar with Market Share for each Hormone Therapy: -Subcategories include Corticosteroids, Hormone Agonists/Antagonists, Aromatase Inhibitors and SERMS...
    Vaccines – The World Market

    Published: February 1, 2007 | Price: $3,995.00 – $7,990.00

    What are the trends that are fueling a new boom in vaccine production and sales? Why is an industry so commonly associated with children finding an increasing marketplace among adult populations? What makes this class of drugs likely to grow at a faster rate than other pharmaceutical products? These are among the questions answered in Kalorama’s in-depth report, Vaccines: The World Market. With the historic success of vaccines in virtually eliminating diseases such as small pox and polio, and with...
    Medical Imaging Markets, Volume IV – Contrast Agents

    Published: February 1, 2007 | Price: $1,995.00 – $5,990.00

    Contrast agents and radiopharmaceuticals have revolutionized in vivo imaging. Technical developments in contrast media and imaging techniques is combining with the trends toward both the functional and molecular understanding of disease to create a rapidly growing marketplace in these agents. The introduction and now brisk ongoing development of contrast media for traditional radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, positron-emission tomography (PET), and single-photon emission computed tomography (SPECT), are now allowing for the expansion of diagnostic capabilities of...
    Worldwide Market for Dialysis Equipment, Supplies, and Services, 2nd Edition, The

    Published: February 1, 2007 | Price: $3,300.00 – $7,800.00

    With a growing elderly population, premium pricing, and robust new venues, the kidney dialysis and dialysis equipment market approaches $55 billion worldwide and is expected to grow. With those revenues coming from just 1.6 million patients worldwide, kidney dialysis and equipment is among the most lucrative medical treatment markets in per-capita terms. Kalorama’s Worldwide Market for Kidney Dialysis and Equipment is your key to this burgeoning industry. The report breaks down both the 45 billion-dollar dialysis care market and the...
    Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies)

    Published: January 1, 2007 | Price: $1,100.00 – $7,800.00

    Wireless technologies and healthcare are a perfect fit. The clinical environment is a highly mobile one, and physicians, nurses and other clinical operators have a real need for fast information and action. With a record of successful implementations across aspects of healthcare from patient care to sales, wireless technologies have moved from conjecture to reality. Hospitals are dedicating large portions of current and future budgets to IT development and wireless is likely to be among their choices. Given these trends,...
    Cell Culture – The World Market for Media, Sera, and Reagents

    Published: January 1, 2007 | Price: $3,900.00 – $7,800.00

    As the biopharmaceutical market grows, so will the cell culture products market. Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals. This report is focused on cell culture used in the research and...
    Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs, World Market

    Published: January 1, 2007 | Price: $995.00 – $7,000.00

    The market for psychotherapeutics drugs is about to change dramatically -- and serious pharmaceutical market watchers will want to be prepared. Kalorama’s Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs: World Market is the most exhaustive guide available to this booming market and the direction it is headed in the next four years. Psychotherapeutics treat conditions classified as abnormal behavior, thoughts and feelings that persist for a determined amount of time causing distress or emotional/physical impairment. Depression, anxiety, psychosis, ADHD and nicotine and...
    Biomarkers – A Market Briefing

    Published: January 1, 2007 | Price: $995.00 – $3,990.00

    Personalized medicine, the use of therapies that are targeted to the individual patient, is a reality today, thanks to a growing emphasis on biomarker research. Biomarkers promise a smoother integration of diagnostics and therapeutics, and most importantly a reduction in time and cost for Phase I and II clinical trials. Anyone looking to take advantage of the opportunities the market for biomarker research offers will find Kalorama’s Biomarkers: A Market Briefing an essential study of this emerging market. Not only...
    Clinical Diagnostics in India – Market Sector Analyses and Participant Directory

    Published: December 1, 2006 | Price: $4,500.00 – $9,990.00

    The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices become established. This comprehensive report on the market for clinical in vitro diagnostic (IVD) tests in India covers both reagent and instrumentation markets for the...
    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    Published: November 1, 2006 | Price: $1,500.00 – $5,990.00

    This report takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. There is also an emphasis on early disease detection via rapid test use in clinics and public venues. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place. The field for rapid test devices is crowded; worldwide,...
    Mass Spectrometry in Protein Biomarker Applications – Software, Services, and Instrument Markets

    Published: November 1, 2006 | Price: $995.00 – $5,990.00

    Protein biomarkers have become the hot application area for mass spectrometry (MS) and other proteomics-related technologies in the last few years. In the short term, this move towards biomarkers and clinical proteomics research has happened mainly in the drug discovery and development process. However, they also have broad abilities to generate richer information about a disease state, drug response, and/ or the relation between the two; which can be used for diagnostic, prognostic, or various other purposes in the pharmaceutical,...
    The Emerging Cancer Vaccine Market, 2nd Edition

    Published: November 1, 2006 | Price: $1,200.00 – $7,000.00

    Propelled by advances in molecular biology, the cancer vaccine industry is poised for unprecedented growth. This second edition of Kalorama’s groundbreaking 2003 study completely updates the market data and reviews the technological, clinical, and business trends that have shaped and reshaped this emerging field. Specific segments covered in the report include: Cervical cancer, Colorectal cancer, Lung cancer, Lymphoma, Melanoma, Prostate cancer, and Other cancers for which vaccines are in development. Each market segment provides an overview, descriptions of products available...
    Biophotonics – A Strategic Assessment of Photonics Technologies for Biomedical Applications

    Published: November 1, 2006 | Price: $2,995.00 – $5,990.00

    Collectively, the techniques of photon-based experimental manipulation and advanced optical imaging define the field of biophotonics. There are several key areas that are associated with biophotonics. All of these center on microscopy and related technology. The reason that this is so is that biophotonics look at biological functions at the cellular level, or even smaller. The only way that these processes can be observed is via one or another form of microscopy. Among the different types of microscopy and associated...
    Medical Imaging Markets, Volume III – Ultrasound

    Published: October 1, 2006 | Price: $1,200.00 – $5,990.00

    Ultrasound, also known as sonography, is not a new imaging modality—having been around since the 1950s—but its application areas have just recently begun to expand tremendously. These new clinical applications, along with technological innovations in portability and resolution and a very favorable risk profile, have made ultrasound equipment a very robust market sector. This third volume in Kalorama’s ongoing series on medical imaging examines the market for ultrasound equipment worldwide, reviewing the drivers and restraints, the established and emerging application...